TT
Tenax Therapeutics Inc
🇺🇸XNAS.TENXUnited StatesHealthcare
$1.86USDup +0.04 (+2.2%)ClosedEnd of day1:09 AM
Price$1.86+0.04 (+2.2%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US88032L6056
- CUSIP
- 69207P100
Company
- Employees
- 14
- Headquarters
- Chapel Hill, United States
- Website
- https://www.tenaxthera.com
- CEO
- Mr. Christopher T. Giordano
Market
- Shares outstanding
- 37.4M
- Market cap
- $69.61M
Highlights
- Market cap
- $68.11M
- EPS LTM
- -$1.28
- P/E LTM
- -11.41
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$64.86M-106.03%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$46.03M-131.95%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.